Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$169K Buy
2,350
+2,046
+673% +$193K 0.12% 60
2026
Q1
$35.9K Buy
304
+2
+0.7% +$247 0.02% 103
2025
Q4
$38.1K Sell
302
-14,408
-98% -$1.88M 0.02% 99
2025
Q3
$2.15M Buy
14,710
+792
+6% +$120K 1.38% 26
2025
Q2
$2.17M Buy
+13,918
New +$2.21M 1.54% 25

Other funds holding ZTS

Syntax Research's ZTS Position: Q2 2026 in Review

Syntax Research increased its Zoetis (ZTS) stake by 673% in Q2 2026, buying an estimated $193K and bringing the position to 2,350 shares worth $169K. The position accounts for 0.12% of the portfolio, ranked #60.

Syntax Research first reported a position in ZTS in Q2 2025 and has held it in 5 quarters since. The position peaked at $2.17M in Q2 2025. 1,429 funds tracked by Wall St. Rank hold ZTS as of Q2 2026.

  • Syntax Research held 2,350 shares of Zoetis worth $169K as of Q2 2026.
  • Syntax Research bought 2,046 Zoetis shares in Q2 2026, an estimated $193K.
  • Zoetis made up 0.12% of Syntax Research's portfolio in Q2 2026, its #60 holding.
  • Syntax Research first reported a position in Zoetis in Q2 2025 and has held it in 5 quarters since.
  • Syntax Research's Zoetis position peaked at $2.17M in Q2 2025.
  • 1,429 funds tracked by Wall St. Rank held Zoetis as of Q2 2026.

Based on Syntax Research's 13F filing for Q2 2026, filed 31 Jul 2026.